Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Xymogen and Acasti Pharma Launch LipiChol540 - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Xymogen and Acasti Pharma Launch LipiChol540

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Xymogen, Orlando, FL, has announced an exclusive partnership with Acasti Pharma, Québec, Canada, the biopharmaceutical company with whom they will launch the distribution of LipiChol540, a physician-prescribed medical food to manage omega 3 phospholipid deficiency. The formula will be distributed by Pharmaceutix Medical Foods, a wholly owned subsidiary of Xymogen. LipiChol540 is the only medical krill oil product in the world. It is pharmaceutically formulated to provide a stronger dosage and lower pill burden, compared to popular fish oil supplements, without the typical unpleasant taste or burping side effects.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics